209 results on '"Riondino S"'
Search Results
2. Obesity and common pathways of cancer and cardiovascular disease
3. Biological and predictive role of ERCC1 polymorphisms in cancer
4. Biospecimen Digital Twins: Moving from a 'High Quality' to a 'Fit-for-Purpose' Concept in the Era of Omics Sciences
5. 369P Irinotecan is superior to oxaliplatin in KRAS-G12C-mutated (K-G12C-m) colorectal cancer (CRC) and should be preferred in combination strategies with K-G12C inhibitors. A multicenter propensity score-matched (PSM) retrospective analysis
6. Clinical models and biochemical predictors of VTE in lung cancer
7. 492P Vitamin D deficiency in metastatic colorectal cancer (mCRC) worsens survival and correlates with significant peripheral inflammatory/immune cell changes
8. 920P The sarcopenia skeletal muscle mass index (SMI) has a three-tier survival effect in HNSCC, which can be predicted by hemoglobin (Hb), lymphocytes (Ly) and creatinine (Cre)
9. Predictive value of HDL cholesterol for cancer-associated venous thromboembolism during chemotherapy
10. P-148 Perfect concordance between blood-based and normal tissue-based dihydropyrimidine dehydrogenase polymorphisms suggests that pharmacogenetic screening could be contextual to tumour molecular profiling
11. P-162 Universally adopted vitamin D deficiency cutoff of 10 ng/mL is optimal for metastatic colorectal cancer prognostication and correlated with neutrophil/lymphocyte ratio
12. More on: aspirin resistance: position paper of the Working Group on Aspirin Resistance. Proposal for a Laboratory Test Guiding Algorithm
13. Further evidence that fibrillar collagen is unable to promote platelet shape change and aggregation in the absence of secondary agonists. A rebuttal
14. Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin
15. Cisplatin plus capecitabine (CisCape) and concurrent pelvic radiotheapy for the neoadjuvant treatment of rectal cancer (RC)
16. Oxidant stress as a major determinant of platelet activation in invasive breast cancer
17. Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle
18. The tailored nutritional counseling in early cancer patients
19. Music intervention during chemotherapy infusion reduces anxiety in oncological patients
20. Evaluation of QoL as a predictor of chemotherapy-induced toxicity
21. Random optimization interactive system based on Kernel learning (RISK) for venous thromboembolism risk assessment in chemotherapy-treated cancer patients
22. Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio
23. Impact of chemotherapy on activated protein C-dependent thrombin generation--association with VTE occurrence
24. Cisplatin plus capecitabine (CisCape) and concurrent pelvic radiotheapy for the neoadjuvant treatment of rectal cancer (RC)
25. Body Mass Index (BMI) e quality of life (QoL) in cancer patients – the ‘Tor Vergata’ Observational study in oNCOlogy– TV-ONCO study
26. 1571 Ideal Body Mass Index (BMI) is significantly different between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy
27. 260 Activation of blood coagulation in breast cancer - relationship to clinical outcome
28. 261 The insulin-glucose axis in breast cancer - relationship to clinical outcome
29. Influenza della Rosuvastatina sull’attività antiaggregante del Clopidogrel nei pazienti con Sindrome Coronarica Acuta
30. Rosuvastatin effects on platelet inhibition by Clopidogrel in cardiovascular patients
31. S8 - The tailored nutritional counseling in early cancer patients
32. R6 - Evaluation of QoL as a predictor of chemotherapy-induced toxicity
33. R3 - Music intervention during chemotherapy infusion reduces anxiety in oncological patients
34. 1564P - Random optimization interactive system based on Kernel learning (RISK) for venous thromboembolism risk assessment in chemotherapy-treated cancer patients
35. Type 1 and 2 diabetic patients under chronic aspirin treatment exhibit a persistent platelet thromboxane-A2 production
36. Interindividual variability of platelet sensitivity to aspirin is due to impaired platelet COX-1/Aspirin interaction
37. Reduced platelet sensitivity to aspirin in type 2 diabetic subjects compared to non-diabetics
38. Aspirin does not equally inhibit thromboxane A2 formation in long-term treated patients
39. Persistent production of thromboxane A2 in patients chronically treated with aspirin
40. Collagen-induced platelet thromboxane A2 production in patients chronically treated with aspirin
41. Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy
42. Impact of chemotherapy on venous thromboembolism: Comment to: Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study
43. COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment
44. Obesity-Driven Inflammation and Colorectal Cancer
45. 799 Novel High-sensitive D-dimer Determination Predicts Chemotherapy-associated Venous Thromboembolism in Cancer Patients
46. 1102 POSTER High-sensitive D-dimer Determination for the Prediction of Chemotherapy-associated Venous Thromboembolism in Lung Cancer Patients
47. COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment
48. Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention
49. DIFFERENTIAL AGGREGATION OF THROMBIN-DEGRANULATED HUMAN PLATELETS IN RESPONSE TO ADP, EPINEPHRINE AND SQ26655
50. cAMP inhibits convulxin-induced calcium mobilization; differences with collagen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.